Murali Dharan Bashyam (Murali D Bashyam)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Intellectual Disability

Top Venues

Journal of cellular biochemistry

Journal of molecular medicine (Berlin, Germany)

American journal of medical genetics. Part A

This page only lists publications with an associated author ORCID identifier.

Publications

Asmita Gupta, Sumedha Avadhanula, Murali Dharan Bashyam
Evaluation of the gene fusion landscape in early onset sporadic rectal cancer reveals association with chromatin architecture and genome stability. Oncogene 43 (32) (2024)
Sara A George, Viswakalyan Kotapalli, Pandilla Ramaswamy, Raju Kumar, Swarnalata Gowrishankar, Shantveer G Uppin, Murali Dharan Bashyam
Novel oncogenic transcriptional targets of mutant p53 in esophageal squamous cell carcinoma. Journal of cellular biochemistry 125 (4) (2024)
Asmita Gupta, Sumedha Avadhanula, Murali Dharan Bashyam
Evaluation of the gene fusion landscape in early onset sporadic rectal cancer reveals association with chromatin architecture and genome stability. Oncogene (2024)
Asmita Gupta, Sumedha Avadhanula, Murali Dharan Bashyam
Evaluation of the gene fusion landscape in early onset sporadic rectal cancer reveals association with chromatin architecture and genome stability. Oncogene 43 (32) (2024)
Sara A George, Viswakalyan Kotapalli, Pandilla Ramaswamy, Raju Kumar, Swarnalata Gowrishankar, Shantveer G Uppin, Murali Dharan Bashyam
Novel oncogenic transcriptional targets of mutant p53 in esophageal squamous cell carcinoma. Journal of cellular biochemistry (2024)
Sara A George, Viswakalyan Kotapalli, Pandilla Ramaswamy, Raju Kumar, Swarnalata Gowrishankar, Shantveer G Uppin, Murali Dharan Bashyam
Novel oncogenic transcriptional targets of mutant p53 in esophageal squamous cell carcinoma. Journal of cellular biochemistry 125 (4) (2024)
Sara A George, Viswakalyan Kotapalli, Pandilla Ramaswamy, Raju Kumar, Swarnalata Gowrishankar, Shantveer G Uppin, Murali Dharan Bashyam
Novel oncogenic transcriptional targets of mutant p53 in esophageal squamous cell carcinoma. Journal of cellular biochemistry 125 (4) (2024)
Francisco Cammarata-Scalisi, Michele Callea, Ajay Kumar Chaudhary, Antonio Cárdenas Tadich, Maykol Araya Castillo, Antonino Morabito, Emanuele Bellacchio, Elisa Pisaneschi, Antonio Novelli, Colin Eric Willoughby, Murali Dharan Bashyam
Novel EDA mutations cause X-linked hypohidrotic ectodermal dysplasia: the first study from Venezuela. Clinical and experimental dermatology (2023)
Asmita Gupta, Reelina Basu, Murali Dharan Bashyam
Assessing the evolution of SARS-CoV-2 lineages and the dynamic associations between nucleotide variations. Access microbiology 5 (7) (2023)
Pratyusha Bala, Padmavathi Kavadipula, Sanjana Sarkar, Murali Dharan Bashyam
To β or Not to β: Lack of Correlation Between APC Mutation and β-Catenin Nuclear Localization in Colorectal Cancer. Journal of gastrointestinal cancer (2022)
Ajay Kumar Chaudhary, Aishwarya Gholse, Hampapathalu Adimurthy Nagarajaram, Ashwin Bhikaji Dalal, Neerja Gupta, Atanu Kumar Dutta, Sumita Danda, Rekha Gupta, Hariharan V Sankar, Gandham SriLakshmi Bhavani, Katta Mohan Girisha, Shubha Rao Phadke, Prajnya Ranganath, Murali Dharan Bashyam
Ectodysplasin pathogenic variants affecting the furin-cleavage site and unusual clinical features define X-linked hypohidrotic ectodermal dysplasia in India. American journal of medical genetics. Part A (2021)
Srinivas Animireddy, Padmavathi Kavadipula, Viswakalyan Kotapalli, Swarnalata Gowrishankar, Satish Rao, Murali Dharan Bashyam
Aberrant cytoplasmic localization of ARID1B activates ERK signaling and promotes oncogenesis. Journal of cell science 134 (4) (2021)
Pratyusha Bala, Anurag Kumar Singh, Padmavathi Kavadipula, Viswakalyan Kotapalli, Radhakrishnan Sabarinathan, Murali Dharan Bashyam
Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer. Oncogene 40 (4) (2020)
Raju S R Adduri, Sara A George, Padmavathi Kavadipula, Murali Dharan Bashyam
SMARCD1 is a transcriptional target of specific non-hotspot mutant p53 forms. Journal of cellular physiology 235 (5) (2019)
Raju Kumar, Viswakalyan Kotapalli, Ashmala Naz, Swarnalata Gowrishankar, Satish Rao, Jonathan R Pollack, Murali Dharan Bashyam
XPNPEP3 is a novel transcriptional target of canonical Wnt/β-catenin signaling. Genes, chromosomes & cancer 57 (6) (2018)
Raju Kumar, Ratheesh Raman, Viswakalyan Kotapalli, Swarnalata Gowrishankar, Saumyadipta Pyne, Jonathan R Pollack, Murali Dharan Bashyam
Ca2+/nuclear factor of activated T cells signaling is enriched in early-onset rectal tumors devoid of canonical Wnt activation. Journal of molecular medicine (Berlin, Germany) 96 (2) (2017)